PDF下载 ( 1095 KB)
Recent advances in understanding the relations between liver cirrhosis and sleep disorders
-
摘要:
肝硬化患者常表现出睡眠障碍,最新研究显示睡眠障碍或许与肝硬化患者不良预后有关。本文讨论睡眠障碍与肝性脑病(HE)和肝肺综合征(HPS)等肝硬化并发症之间的关系,并对其在原发性胆汗性肝硬化、丙型肝炎、非酒精性脂肪肝、wilson病等几种特殊病因引起的肝硬化中的作用作一综述。
Abstract:Liver cirrhosis patients frequently experience sleep disorders, and the latest research findings have indicated that the presence of sleep disorders may be correlated with poor prognosis in this patient population.In this review, the specific cirrhosis complications, including hepatic encephalopathy-decompensated cirrhosis and hepatopulmonary syndrome, as well as the etiologic factors of cirrhosis, including primary biliary cirrhosis, hepatitis C virus infection, non-alcoholic fatty liver disease and Wilson's disease, associated with sleep disorders are discussed.Findings from animal and clinical studies, such as those using dominant frequency analysis by electroencephalography to detect brain dysfunction under specific conditions and molecular analyses that have provided insights into the mechanisms related to gas exchange mechanisms, are detailed along with results of promising drug treatments.
-
Key words:
- liver cirrhosis /
- sleep disorders /
- electroencephalogram
-
[1]Jiang H, Xie Q.Advances in the diagnosis and treatment of hepaticencephalopathy[J].J Clin Hepatol, 2011, 27 (10) :1027-1031. (in Chinese) 姜浩, 谢青.肝性脑病临床诊治的进展[J].临床肝胆病杂志, 2011, 27 (10) :1027-1031. [2] Mostacci B, Ferlisi M, Baldi Antognini A, et al.Sleep disturbance anddaytime sleepiness in patients with cirrhosis:a case control study[J].Neurol Sci, 2008, 29 (4) :237-240. [3]Montagnese S, Middleton B, Skene DJ, et al.Night-time sleepdisturbance does not correlate with neuropsychiatric impairment inpatients with cirrhosis[J].Liver Int, 2009, 29 (9) :1372-1382. [4]Jiménez-Anguiano A, Díaz-Medina V, Farfán-Labonne BE, etal.Modification of sleep architecture in an animal model of experi-mental cirrhosis[J].World J Gastroenterol, 2009, 15 (41) :5176-5180. [5]Kanwal F, Gralnek IM, Hays RD, et al.Health-related quality oflife predicts mortality in patients with advanced chronic liver disease[J].Clin Gastroenterol Hepatol, 2009, 7 (7) :793-799. [6]Lu DY, Wen B, He F.Clincal efficacy of naloxone in treatment ofhepatic encephalopathy[J].J Clin Exp Med, 2012, 11 (9) :703, 705. (in Chinese) 陆德云, 温彪, 何峰.纳洛酮治疗肝性脑病的临床疗效观察[J].临床和实验医学杂志, 2012, 11 (9) :703, 705. [7]Wei X, Cheng WL, Zhang RZ.A Clinical study of rhubarb decoc-tion in treatment of mild hepatic encephalopathy[J].J Chang chunUni Tradit Chin Med, 2011, 27 (1) :26-27.韦新, 程万里, 张荣臻.大黄煎剂治疗轻微肝性脑病的临床研究[J].长春中医药大学报, 2011, 27 (1) :26-27. [8]Marchetti P, D'Avanzo C, Orsato R.Electroencephalography in pa-tients with cirrhosis[J].Gastroenterology, 2011, 141 (5) :1680-1689.e1-2. [9]Llansola M, Cantero JL, Hita-Yanez E, et al.Progressive reduc-tion of sleep time and quality in rats with hepaticencephalopathycaused by portacaval shunts[J].Neuroscience, 2012, 201:199-208. [10]Farjam M, Dehdab P, Abbassnia F, et al.Thioacetamide-inducedacute hepatic encephalopathy in rat:behavioral, biochemical andhistological changes[J].Iran Red Crescent Med J, 2012, 14 (3) :164-170. [11]Mostacci B, Ferlisi M, Baldi AA, et al.Sleep disturbance and daytimesleepiness in patients with cirrhosis:a casecontrol study[J].NeurolSci, 2008, 29 (4) :237-240. [12]Montagnese S, Middleton B, Skene DJ, et al.Night-time sleepdisturbance does not correlate with neuropsychiatric impairment inpatients with cirrhosis[J].Liver Int, 2009, 29 (9) :1372-1382. [13]Spahr L, Coeytaux A, Giostra E, et al.Histamine H1 blockerhydroxyzine improves sleep in patients with cirrhosis andminimalhepatic encephalopathy:a randomized controlled pilot trial[J].Am J Gastroenterol, 2007, 102 (4) :744-753. [14]Palma DT, Philips GM, Arguedas MR, et al.Oxygen desaturationduring sleep in hepatopulmonary syndrome[J].Hepatology, 2008, 47 (4) :1257-1263. [15]Halank M, Langner S, Kolditz M, et al.Nocturnal oxygen desaturationis a frequent complication in portopulmonary hypertension[J].Z Gas-troenterol, 2008, 46 (11) :1260-1265. [16]Jones DE, Al-Rifai A, Frith J, et al.The independent effects of fa-tigue and UDCA therapy on mortality in primary biliary cirrhosis:re-sults of a 9 year follow-up[J].J Hepatol, 2010, 53 (5) :911-917. [17]Jones DE, Newton JL.An open study of modafinil for the treatmentof daytime somnolence and fatigue in primary biliary cirrhosis[J].Aliment Pharmacol Ther, 2007, 25 (4) :471-476. [18]Hardy T, MacDonald C, Jones DE, et al.A follow-up study ofmodafinil for the treatment of daytime somnolence and fatigue in pri-mary biliary cirrhosis[J].Liver Int, 2010, 30 (10) :1551-1552. [19]Carlson MD, Hilsabeck RC, Barakat F, et al.Role of sleep dis-turbance in chronic hepatitis C infection[J].Curr Hepat Rep, 2010, 9 (1) :25-29. [20]Raison CL, Rye DB, Woolwine BJ, et al.Chronic interferon-al-pha administration disrupts sleep continuity and depth in patientswith hepatitis C:association with fatigue, motor slowing, and in-creased evening cortisol[J].Biol Psychiatry, 2010, 68 (10) :942-949. [21]Sockalingam S, Abbey SE, Alosaimi F, et al.A review of sleepdisturbance in hepatitis C[J].J Clin Gastroenterol, 2010, 44 (1) :38-45. [22]de Almeida CM, de Lima TA, Castro DB, et al.Immunological/virological peripheral blood biomarkers and distinct patterns of sleep-ing quality in chronic hepatitis C patients[J].Scand J Immunol, 2011, 73 (5) :486-495. [23]Rabkin JG, McElhiney MC, Rabkin R.Modafinil and armodafinil treat-ment for fatigue for HIV-positive patients with and without chronic hepa-titis C[J].Int J STD AIDS, 2011, 22 (2) :95-101. [24]Martin KA, Krahn LE, Balan V, et al.Modafinil's use in comba-ting interferon-induced fatigue[J].Dig Dis Sci, 2007, 52 (4) :893-896. [25]Chin K, Nakamura T, Takahashi K, et al.Effects of obstructive sleepapnea syndrome on serum aminotransferase levels in obese patients[J].Am J Med, 2003, 114 (5) :370-376. [26]Shpirer I, Copel L, Broide E, et al.Continuous positive airwaypressure improves sleep apnea associated fatty liver[J].Lung, 2010, 188 (4) :301-307. [27]Kohler M, Pepperell JC, Davies RJ, et al.Continuous positive air-way pressure and liver enzymes in obstructive sleep apnoea:datafrom a randomized controlled trial[J].Respiration, 2009, 78 (2) :141-146. [28]Piguet AC, Stroka D, Zimmermann A, et al.Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN[J].ClinSci (Lond) , 2010, 118 (6) :401-410. [29]Spisni E, Valerii MC, Manerba M, et al.Effect of copper on extra-cellular levels of key pro-inflammatory molecules in hypothalamicGN11 and primary neurons[J].Neurotoxicology, 2009, 30 (4) :605-612. [30]Nevsimalova S, Buskova J, Bruha R, et al.Sleep disorders in Wilson's disease[J].Eur J Neurol, 2011, 18 (1) :184-190. [31]Netto AB, Sinha S, Taly AB, et al.Sleep in Wilson's disease:questionnaire based study[J].Ann Indian Acad Neurol, 2011, 14 (1) :31-34. [32]Netto AB, Sinha S, Taly AB, et al.Sleep in Wilson's disease:apolysomnography-based study[J].Neurol India, 2010, 58 (6) :933-938. [33]Franco RA, Ashwathnarayan R, Deshpandee A, et al.The highprevalence of restless legs syndrome symptoms in liver disease in anacademic-based hepatology practice[J].J Clin Sleep Med, 2008, 4 (1) :45-49. [34]Rodrigue JR, Nelson DR, Reed AI, et al.Fatigue and sleep qualitybefore and after liver transplantation[J].Prog Transplant, 2010, 20 (3) :221-233. -
本文二维码
计量
- 文章访问数: 3389
- HTML全文浏览量: 16
- PDF下载量: 724
- 被引次数: 0
下载:
